|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$331||Benefits minus costs||$1,633|
|Participants||$432||Benefit to cost ratio||$6.40|
|Others||$167||Chance the program will produce|
|Indirect||$1,007||benefits greater than the costs||53 %|
|Net program cost||($302)|
|Benefits minus cost||$1,633|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Any criminal conviction according to court records, sometimes measured through charges, arrests, incarceration, or self-report.
Illicit drug use disorder
Clinical diagnosis of illicit drug use disorder or symptoms measured on a validated scale. When possible, we exclude cannabis/marijuana use disorder from this outcome.
Substance use disorder^
A non-specified alcohol or drug use disorder. Typically, a collection of different types of disorders reported by study authors.
Any employment, including part-time work.
Number of hours worked in a given time period.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Crime||Criminal justice system||$3||$0||$9||$2||$13|
|Illicit drug use disorder||Labor market earnings associated with illicit drug abuse or dependence||$129||$302||$0||$0||$430|
|Health care associated with illicit drug abuse or dependence||$154||$24||$158||$77||$413|
|Mortality associated with illicit drugs||$45||$106||$0||$1,079||$1,230|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($151)||($151)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$287||2016||Present value of net program costs (in 2018 dollars)||($302)|
|Comparison costs||$0||2016||Cost range (+ or -)||10 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Jason, L.A., & Ferrari, J.R. (2010). Oxford House recovery homes: Characteristics and effectiveness. Psychological Services, 7(2), 92-102.
Jason, L.A., Olson, B.D., Ferrari, J.R., & Lo Sasso, A.T. (2006). Communal housing settings enhance substance abuse recovery. American Journal of Public Health, 96(10), 1727.
Jason, L.A., Olson, B.D., & Harvey, R. (2015). Evaluating alternative aftercare models for ex-offenders. Journal of Drug Issues, 45(1), 53-68.
Lo Sasso. A.T., Byro, E., Jason, L.A., Ferrari, J.R., & Olson, B. (2012). Benefits and costs associated with mutual-help community-based recovery homes: The Oxford House model. Evaluation and Program Planning, 35(1), 47-53.
Tuten, M., Defulio, A., Jones, H.E., & Stitzer, M. (2012). Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification. Addiction, 107(5), 973-982.